Skip to main content
Fri, Mar 20, 2026
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
ScienceUnited Kingdom1 sourcesNeutral

Crossbow raises $77M series B for T-cell mimicking antibodies

Crossbow Therapeutics Inc. closed a $77 million series B round to support an ongoing phase I Crosscheck-001 trial of lead program, CBX-250, and additional T-Bolt immunotherapies targeting a broad range of cancers.

MC
marian chu
via Bioworld
ShareRead original

Read the full article at Bioworld →

Crossbow raises $77M series B for T-cell mimicking antibodies

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Bioworld
Bioworld
NewsDataUK

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Provider consolidation slammed in latest House affordability hearing
Next
M.T.A. Aims to Replace Thousands of Aging Subway Cars Built in the 1980s

Related Articles

A new study questions when people first reached South AmericaScience
A new study questions when people first reached South America
Science News-12h ago-1 sources
When did plate tectonics on Earth begin? New research finds some of the earliest cluesScience
When did plate tectonics on Earth begin? New research finds some of the earliest clues
Scientificamerican-12h ago-1 sources
Promising Biotech Stocks To Follow Now – March 19thScience
Promising Biotech Stocks To Follow Now – March 19th
The Lincolnian Online-12h ago-1 sources
Crossbow raises $77M series B for T-cell mimicking antibodies | TrendingNews.today